Sermorelin & GHRP-6 & GHRP-2 Triple Blend
A triple-peptide research blend combining sermorelin, GHRP-6, and GHRP-2 for maximal GH pathway stimulation across multiple receptor targets.
Community Rating
No ratings yet
⚠ Research & Educational Use Only. Sermorelin & GHRP-6 & GHRP-2 Triple Blend is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Triple receptor mechanism for maximum GH axis stimulation
- Dual GHRP compounds for amplified somatostatin suppression
- Enhanced IGF-1 response vs dual-peptide combinations
- Sermorelin & GHRP-6 & GHRP-2 Triple Blend is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Triple receptor mechanism for maximum GH axis stimulation
- Dual GHRP compounds for amplified somatostatin suppression
- Enhanced IGF-1 response vs dual-peptide combinations
- Appetite stimulation from GHRP-6 component
What is Sermorelin & GHRP-6 & GHRP-2 Triple Blend?
Tap any underlined term for an instant definition.
The Sermorelin & GHRP-6 & GHRP-2 Triple Blend represents a three-component GH-stimulating research preparation. By combining a GHRH analogue (sermorelin) with two different GHSPs (GHRP-6 and GHRP-2), this blend engages the GH axis through multiple overlapping mechanisms, producing GH responses that exceed dual-peptide combinations in some protocols.
What It Is
- Sermorelin: GHRHR agonist (GHRH pathway)
- GHRP-2: GHS-R1a agonist (pure GH secretagogue, some cortisol/prolactin)
- GHRP-6: GHS-R1a + motilin receptor agonist (GH + appetite stimulation)
- Triple combination for maximum somatotroph stimulation
How It Works
- All three peptides simultaneously engage the GH axis via distinct receptor populations
- GHRP-6 and GHRP-2 together produce additive somatostatin suppression and GH release above either GHRP alone
- Sermorelin adds direct GHRHR activation on top of the dual GHRP effect
- Maximum GH pulse amplitude reported in triple-component studies is 4-6x either single peptide alone
Key Research Findings
- GH amplitude: Triple combination produces highest GH peaks among non-GHRH direct injection protocols
- IGF-1: Sustained elevation of 70-90% above baseline with daily triple combination
- Side effects: Cortisol and prolactin elevation are more pronounced than dual-GHRP protocols; dose reduction of individual GHRPs recommended
Dosing From the Literature
- Sermorelin 100-200 mcg + GHRP-6 100 mcg + GHRP-2 100 mcg per injection
- Lower individual doses prevent excessive cortisol/prolactin elevation
- Once daily at bedtime
Storage and Handling
- Lyophilised: 2-8 degrees C; 24 months
- Reconstituted: 2-8 degrees C; use within 30 days
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Sermorelin & GHRP-6 & GHRP-2 Triple Blend. See all Peptide Blends peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Subcutaneous injection. Reduce individual GHRP doses relative to single-GHRP protocols to manage side effects.
Explore Further
Quick Reference
More in Peptide Blends
- Sermorelin & Ipamorelin Blend
- Sermorelin & GHRP-2 Blend
- Sermorelin & GHRP-6 Blend
- Tesamorelin & Ipamorelin Blend
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.